Vera Therapeutics Inc
Ownership
Ownership Structure
Who owns Vera Therapeutics Inc (VERA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 72.7% of the shares are freely tradable; institutional investors hold 110.6%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 7.98 | 5,747,760 | +13.0 | 06/30/2026 |
| venBio Select Advisor LLC | 7.94 | 5,723,888 | -2.8 | 06/30/2026 |
| State Street Corp | 5.76 | 4,148,786 | +23.3 | 06/30/2026 |
| T. Rowe Price Associates, Inc. | 5.57 | 4,012,936 | -12.3 | 06/30/2026 |
| Deep Track Capital, LP | 5.55 | 4,000,000 | -2.6 | 06/30/2026 |
| Deerfield Management Co | 5.43 | 3,916,400 | +5.2 | 06/30/2026 |
| Kynam Capital Management, LP | 4.01 | 2,890,059 | -15.0 | 06/30/2026 |
| Morgan Stanley - Brokerage Accounts | 3.88 | 2,799,459 | +659.2 | 06/30/2026 |
| Sofinnova Ventures | 3.88 | 2,793,987 | +0.0 | 06/30/2026 |
| FMR Inc | 3.85 | 2,774,070 | +3.6 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Fordyce Marshall | PRESIDENT AND CEO | 235,244 | 7,221,991 $ | Sep 15, 2026 | direct |
| Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | 80,754 | 2,479,148 $ | Sep 11, 2026 | direct |
| Boman Nancy Lee | Chief Regulatory Officer | 44,987 | 1,381,101 $ | Aug 3, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 18,500 | 37.00 | 684,500 |
| Sep 15, 2026 | Fordyce Marshall | PRESIDENT AND CEO | Other | 18,500 | 2.90 | 53,591 |
| Sep 11, 2026 | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | Other | 5,000 | 3.94 | 19,698 |
| Sep 2, 2026 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 18,500 | 35.12 | 649,642 |
| Sep 2, 2026 | Fordyce Marshall | PRESIDENT AND CEO | Other | 18,500 | 2.90 | 53,591 |
| Aug 3, 2026 | Boman Nancy Lee | Chief Regulatory Officer | Other | 44,987 | 0.00 | – |
| Jul 7, 2026 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 2,200 | 43.59 | 95,908 |
| Jul 7, 2026 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 10,500 | 42.86 | 450,007 |
| Jul 7, 2026 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 32,550 | 42.07 | 1,369,496 |
| Jul 7, 2026 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 1,000 | 40.78 | 40,776 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.